

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 5.20742647 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 4.86915802 |
| 3 | glycolipid catabolic process (GO:0019377) | 4.64206052 |
| 4 | barbed-end actin filament capping (GO:0051016) | 4.21635277 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16550539 |
| 6 | protein carboxylation (GO:0018214) | 4.16550539 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14606611 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.13688526 |
| 9 | regulation of early endosome to late endosome transport (GO:2000641) | 4.12530345 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.06093702 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 4.06093702 |
| 12 | ceramide catabolic process (GO:0046514) | 4.05879082 |
| 13 | urea cycle (GO:0000050) | 4.00394796 |
| 14 | urea metabolic process (GO:0019627) | 4.00394796 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.94797487 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 3.94797487 |
| 17 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.84497672 |
| 18 | response to peptidoglycan (GO:0032494) | 3.80905553 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79673862 |
| 20 | amino sugar catabolic process (GO:0046348) | 3.76826630 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 3.72189274 |
| 22 | regulation of mononuclear cell migration (GO:0071675) | 3.68998457 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.67646306 |
| 24 | pinocytosis (GO:0006907) | 3.66727296 |
| 25 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.66076071 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 3.66006293 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 3.65984851 |
| 28 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64626851 |
| 29 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.63567165 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 3.61965590 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.54999806 |
| 32 | regulation of cholesterol homeostasis (GO:2000188) | 3.52883412 |
| 33 | virion attachment to host cell (GO:0019062) | 3.50989853 |
| 34 | adhesion of symbiont to host cell (GO:0044650) | 3.50989853 |
| 35 | complement activation, alternative pathway (GO:0006957) | 3.50117487 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.47674172 |
| 37 | decidualization (GO:0046697) | 3.45242670 |
| 38 | membrane lipid catabolic process (GO:0046466) | 3.44914662 |
| 39 | bile acid biosynthetic process (GO:0006699) | 3.39279414 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36621734 |
| 41 | mannose metabolic process (GO:0006013) | 3.36522790 |
| 42 | sphingolipid catabolic process (GO:0030149) | 3.36108650 |
| 43 | adhesion of symbiont to host (GO:0044406) | 3.35737596 |
| 44 | stress fiber assembly (GO:0043149) | 3.34369829 |
| 45 | response to thyroid hormone (GO:0097066) | 3.33750000 |
| 46 | indole-containing compound catabolic process (GO:0042436) | 3.31230381 |
| 47 | indolalkylamine catabolic process (GO:0046218) | 3.31230381 |
| 48 | tryptophan catabolic process (GO:0006569) | 3.31230381 |
| 49 | regulation of cholesterol storage (GO:0010885) | 3.27185483 |
| 50 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25082259 |
| 51 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.25079354 |
| 52 | phospholipid efflux (GO:0033700) | 3.24776374 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24184722 |
| 54 | cysteine metabolic process (GO:0006534) | 3.23338557 |
| 55 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.23181584 |
| 56 | skin morphogenesis (GO:0043589) | 3.22331601 |
| 57 | modulation by symbiont of host cellular process (GO:0044068) | 3.18511046 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16957278 |
| 59 | cellular response to arsenic-containing substance (GO:0071243) | 3.16297229 |
| 60 | regulation of protein activation cascade (GO:2000257) | 3.13580110 |
| 61 | regulation of fibrinolysis (GO:0051917) | 3.12554517 |
| 62 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.06343484 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.05466749 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.03085978 |
| 65 | macromolecular complex remodeling (GO:0034367) | 3.03085978 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03085978 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02651065 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02651065 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 3.02651065 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02651065 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.02651065 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02651065 |
| 73 | positive regulation of leukocyte degranulation (GO:0043302) | 3.01061953 |
| 74 | cholesterol efflux (GO:0033344) | 2.99468118 |
| 75 | reverse cholesterol transport (GO:0043691) | 2.98740732 |
| 76 | response to laminar fluid shear stress (GO:0034616) | 2.96182092 |
| 77 | negative regulation of cholesterol transport (GO:0032375) | 2.95995246 |
| 78 | negative regulation of sterol transport (GO:0032372) | 2.95995246 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.95993808 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 2.95645050 |
| 81 | myeloid dendritic cell differentiation (GO:0043011) | 2.95528894 |
| 82 | regulation of complement activation (GO:0030449) | 2.94889178 |
| 83 | glutamate metabolic process (GO:0006536) | 2.94458379 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 2.93367625 |
| 85 | adenosine receptor signaling pathway (GO:0001973) | 2.92867848 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.91422519 |
| 87 | hyaluronan catabolic process (GO:0030214) | 2.90618260 |
| 88 | regulation of triglyceride catabolic process (GO:0010896) | 2.90502837 |
| 89 | sulfur amino acid catabolic process (GO:0000098) | 2.90221824 |
| 90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89864914 |
| 91 | hemidesmosome assembly (GO:0031581) | 2.88893766 |
| 92 | glyoxylate metabolic process (GO:0046487) | 2.86909701 |
| 93 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.86252544 |
| 94 | fibrinolysis (GO:0042730) | 2.86178569 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 2.84177438 |
| 96 | acute-phase response (GO:0006953) | 2.82704319 |
| 97 | positive regulation of extracellular matrix organization (GO:1903055) | 2.82066218 |
| 98 | regulation of macrophage chemotaxis (GO:0010758) | 2.81648176 |
| 99 | protein-lipid complex assembly (GO:0065005) | 2.81374184 |
| 100 | regulation of vitamin metabolic process (GO:0030656) | 2.81358037 |
| 101 | macroautophagy (GO:0016236) | 2.79097756 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 2.78823174 |
| 103 | serine family amino acid catabolic process (GO:0009071) | 2.76825730 |
| 104 | bile acid metabolic process (GO:0008206) | 2.76259848 |
| 105 | cell adhesion mediated by integrin (GO:0033627) | 2.75601000 |
| 106 | homocysteine metabolic process (GO:0050667) | 2.75484860 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.75165606 |
| 108 | triglyceride homeostasis (GO:0070328) | 2.74710591 |
| 109 | acylglycerol homeostasis (GO:0055090) | 2.74710591 |
| 110 | macrophage activation involved in immune response (GO:0002281) | 2.74242105 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 2.73403749 |
| 112 | regulation of podosome assembly (GO:0071801) | 2.70469427 |
| 113 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.70262612 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 2.69452631 |
| 115 | aldehyde catabolic process (GO:0046185) | 2.69114834 |
| 116 | response to muramyl dipeptide (GO:0032495) | 2.69086332 |
| 117 | positive regulation of hemostasis (GO:1900048) | 2.69053376 |
| 118 | positive regulation of blood coagulation (GO:0030194) | 2.69053376 |
| 119 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.68777087 |
| 120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68278844 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.67141855 |
| 122 | N-acetylneuraminate metabolic process (GO:0006054) | 2.66097553 |
| 123 | arginine metabolic process (GO:0006525) | 2.64965862 |
| 124 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.64628558 |
| 125 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.64579309 |
| 126 | positive regulation of cholesterol efflux (GO:0010875) | 2.62873025 |
| 127 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61793297 |
| 128 | plasma lipoprotein particle organization (GO:0071827) | 2.60327030 |
| 129 | protein-lipid complex subunit organization (GO:0071825) | 2.60238071 |
| 130 | endodermal cell differentiation (GO:0035987) | 2.59622046 |
| 131 | endocytic recycling (GO:0032456) | 2.58427117 |
| 132 | monocyte chemotaxis (GO:0002548) | 2.58216187 |
| 133 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.57883541 |
| 134 | amino-acid betaine metabolic process (GO:0006577) | 2.57489329 |
| 135 | cellular copper ion homeostasis (GO:0006878) | 2.57061222 |
| 136 | positive regulation of coagulation (GO:0050820) | 2.57008530 |
| 137 | epithelial cell-cell adhesion (GO:0090136) | 2.56376354 |
| 138 | positive regulation of p38MAPK cascade (GO:1900745) | 2.56220775 |
| 139 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.54327030 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.54257309 |
| 141 | phospholipid homeostasis (GO:0055091) | 2.52856984 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.52260975 |
| 143 | aromatic amino acid family metabolic process (GO:0009072) | 2.51824148 |
| 144 | osteoclast differentiation (GO:0030316) | 2.50919919 |
| 145 | tyrosine metabolic process (GO:0006570) | 2.50813856 |
| 146 | regulation of monocyte chemotaxis (GO:0090025) | 2.50729581 |
| 147 | cortical actin cytoskeleton organization (GO:0030866) | 2.50597335 |
| 148 | cofactor catabolic process (GO:0051187) | 2.49845484 |
| 149 | alanine transport (GO:0032328) | 2.48469362 |
| 150 | positive regulation of lipid storage (GO:0010884) | 2.47164150 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46569017 |
| 152 | cell-substrate junction assembly (GO:0007044) | 2.44678004 |
| 153 | lysine catabolic process (GO:0006554) | 2.44585165 |
| 154 | lysine metabolic process (GO:0006553) | 2.44585165 |
| 155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.44294533 |
| 156 | alpha-amino acid catabolic process (GO:1901606) | 2.43179312 |
| 157 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.41137744 |
| 158 | lipoprotein transport (GO:0042953) | 2.41003634 |
| 159 | glial cell migration (GO:0008347) | 2.40461326 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.39986682 |
| 161 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.39574655 |
| 162 | lipoprotein metabolic process (GO:0042157) | 2.38772852 |
| 163 | regulation of chemokine biosynthetic process (GO:0045073) | 2.37503615 |
| 164 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.36779523 |
| 165 | coenzyme catabolic process (GO:0009109) | 2.35999163 |
| 166 | regulation of superoxide anion generation (GO:0032928) | 2.35142944 |
| 167 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.34761348 |
| 168 | activation of MAPKKK activity (GO:0000185) | 2.34639190 |
| 169 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.34630155 |
| 170 | growth hormone receptor signaling pathway (GO:0060396) | 2.34558978 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.34410670 |
| 172 | regulation of lipid catabolic process (GO:0050994) | 2.33957740 |
| 173 | eosinophil chemotaxis (GO:0048245) | 2.32482012 |
| 174 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.31408083 |
| 175 | positive regulation of interferon-alpha production (GO:0032727) | 2.31366599 |
| 176 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.31248709 |
| 177 | protein localization to endosome (GO:0036010) | 2.31246334 |
| 178 | regulation of plasminogen activation (GO:0010755) | 2.31123910 |
| 179 | COPI coating of Golgi vesicle (GO:0048205) | 2.30451436 |
| 180 | Golgi transport vesicle coating (GO:0048200) | 2.30451436 |
| 181 | modulation by virus of host process (GO:0019054) | 2.30443061 |
| 182 | dendritic cell differentiation (GO:0097028) | 2.30251107 |
| 183 | myeloid dendritic cell activation (GO:0001773) | 2.30178904 |
| 184 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.28997167 |
| 185 | response to progesterone (GO:0032570) | 2.26990027 |
| 186 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.26770819 |
| 187 | negative regulation of interleukin-17 production (GO:0032700) | 2.25823739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.54984174 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18174258 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.71454006 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60584383 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.89952694 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85622691 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68742752 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.64246551 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51338073 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.44077810 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38143675 |
| 12 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.33240502 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22168753 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21573450 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.20948195 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19152891 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16567331 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.09216612 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05786157 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02378592 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97748351 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96150520 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86945686 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86384114 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80972233 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77030966 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.74929745 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73677455 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71347354 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59116436 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56786739 |
| 32 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53519107 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53082788 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48842049 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47472476 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47367728 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45027228 |
| 38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43910721 |
| 39 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40585733 |
| 40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39342481 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38807376 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37188089 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.35465469 |
| 44 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.33018870 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32940966 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31845392 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30020554 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29666963 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29603421 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28016855 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27049983 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26634369 |
| 53 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26151066 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26129157 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25327013 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24615025 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23953144 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22859146 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22780295 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22342631 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21746066 |
| 62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21200068 |
| 63 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21200068 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20751430 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20473342 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20405403 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20326768 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20179690 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.19415766 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19396304 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18929963 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16983968 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16844369 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15279600 |
| 75 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14239328 |
| 76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10678252 |
| 77 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10616769 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10021691 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09615189 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09357986 |
| 81 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08633906 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08421253 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07865402 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06801657 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06424249 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06268959 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06212851 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.04599026 |
| 89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03386085 |
| 90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03262281 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02956072 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02921325 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02185475 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01158209 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00455456 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00398683 |
| 97 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00368516 |
| 98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99937721 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99821565 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99498144 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98175297 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98140386 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98034747 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97918921 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97777845 |
| 106 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96200292 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95109409 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94430308 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93712291 |
| 110 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.93675471 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93385031 |
| 112 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92668743 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92248905 |
| 114 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90604382 |
| 115 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89909975 |
| 116 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89909975 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88995194 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88637611 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88226700 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87708330 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86591050 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83862256 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83552440 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.82999267 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82438924 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.80413762 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80155648 |
| 128 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78950854 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78562886 |
| 130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.76119395 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75960756 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75197398 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75156414 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74864189 |
| 135 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74419329 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74149202 |
| 137 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.73431288 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71549004 |
| 139 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.70878814 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70797977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.69611666 |
| 2 | MP0005360_urolithiasis | 4.37964707 |
| 3 | MP0009840_abnormal_foam_cell | 3.49300037 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.39583887 |
| 5 | MP0003303_peritoneal_inflammation | 3.33688943 |
| 6 | MP0005365_abnormal_bile_salt | 3.11481495 |
| 7 | MP0003252_abnormal_bile_duct | 2.75925188 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.68655952 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.68071794 |
| 10 | MP0005083_abnormal_biliary_tract | 2.63991579 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51122495 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.46423605 |
| 13 | MP0003436_decreased_susceptibility_to | 2.45814044 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.42864971 |
| 15 | MP0000604_amyloidosis | 2.32396784 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.31150328 |
| 17 | MP0004510_myositis | 2.29093289 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.16538250 |
| 19 | MP0004858_abnormal_nervous_system | 2.13337662 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.99314676 |
| 21 | MP0008260_abnormal_autophagy | 1.97572194 |
| 22 | MP0003075_altered_response_to | 1.94689240 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.86133043 |
| 24 | MP0006082_CNS_inflammation | 1.85581187 |
| 25 | MP0009278_abnormal_bone_marrow | 1.81695690 |
| 26 | MP0003195_calcinosis | 1.72498117 |
| 27 | MP0002254_reproductive_system_inflammat | 1.70965833 |
| 28 | MP0003690_abnormal_glial_cell | 1.70652971 |
| 29 | MP0000609_abnormal_liver_physiology | 1.70329393 |
| 30 | MP0000858_altered_metastatic_potential | 1.67093566 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.66383178 |
| 32 | MP0005332_abnormal_amino_acid | 1.66040106 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.59997715 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.57695891 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.55622607 |
| 36 | MP0004947_skin_inflammation | 1.54117912 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.53301280 |
| 38 | MP0003279_aneurysm | 1.51446786 |
| 39 | MP0002419_abnormal_innate_immunity | 1.47087300 |
| 40 | MP0003329_amyloid_beta_deposits | 1.47056444 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.42959962 |
| 42 | MP0005166_decreased_susceptibility_to | 1.39335740 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.39046637 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.39046637 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.36824966 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.33318793 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33259996 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.32797529 |
| 49 | MP0009764_decreased_sensitivity_to | 1.32472642 |
| 50 | * MP0005319_abnormal_enzyme/_coenzyme | 1.28110963 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.27757057 |
| 52 | MP0009785_altered_susceptibility_to | 1.27192938 |
| 53 | MP0001790_abnormal_immune_system | 1.26611031 |
| 54 | MP0005387_immune_system_phenotype | 1.26611031 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.24602268 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.23421424 |
| 57 | MP0001666_abnormal_nutrient_absorption | 1.22954788 |
| 58 | * MP0008469_abnormal_protein_level | 1.22399249 |
| 59 | MP0005025_abnormal_response_to | 1.21619407 |
| 60 | MP0003828_pulmonary_edema | 1.21313681 |
| 61 | MP0001542_abnormal_bone_strength | 1.19336875 |
| 62 | MP0008004_abnormal_stomach_pH | 1.15855522 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.15352387 |
| 64 | MP0000685_abnormal_immune_system | 1.14553754 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.14130155 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.12664757 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.11101640 |
| 68 | MP0002796_impaired_skin_barrier | 1.10327384 |
| 69 | MP0000920_abnormal_myelination | 1.08742346 |
| 70 | MP0005409_darkened_coat_color | 1.07527082 |
| 71 | MP0001958_emphysema | 1.07157162 |
| 72 | MP0005671_abnormal_response_to | 1.06951084 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.06729321 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.06533719 |
| 75 | MP0001216_abnormal_epidermal_layer | 1.06225133 |
| 76 | MP0004130_abnormal_muscle_cell | 1.04850822 |
| 77 | MP0006054_spinal_hemorrhage | 1.04402229 |
| 78 | MP0005076_abnormal_cell_differentiation | 1.04322925 |
| 79 | MP0002405_respiratory_system_inflammati | 1.03578098 |
| 80 | MP0005257_abnormal_intraocular_pressure | 1.01947468 |
| 81 | MP0001845_abnormal_inflammatory_respons | 1.01672015 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.00936091 |
| 83 | MP0003724_increased_susceptibility_to | 0.99971730 |
| 84 | MP0002060_abnormal_skin_morphology | 0.99363840 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.99305929 |
| 86 | MP0004233_abnormal_muscle_weight | 0.97671971 |
| 87 | MP0005310_abnormal_salivary_gland | 0.97211998 |
| 88 | MP0005165_increased_susceptibility_to | 0.96769655 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.96356762 |
| 90 | MP0005535_abnormal_body_temperature | 0.95844388 |
| 91 | MP0005275_abnormal_skin_tensile | 0.94855506 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.94003450 |
| 93 | MP0005164_abnormal_response_to | 0.93260010 |
| 94 | MP0009763_increased_sensitivity_to | 0.92854992 |
| 95 | MP0002723_abnormal_immune_serum | 0.92571861 |
| 96 | MP0000598_abnormal_liver_morphology | 0.92349099 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.91896775 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.91610868 |
| 99 | MP0005390_skeleton_phenotype | 0.91002143 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.90403898 |
| 101 | MP0001819_abnormal_immune_cell | 0.89794602 |
| 102 | MP0002090_abnormal_vision | 0.89165840 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.88949462 |
| 104 | MP0002452_abnormal_antigen_presenting | 0.87774791 |
| 105 | * MP0003634_abnormal_glial_cell | 0.87214085 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.86845710 |
| 107 | MP0003045_fibrosis | 0.85477239 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.83731084 |
| 109 | MP0001800_abnormal_humoral_immune | 0.82855036 |
| 110 | MP0003795_abnormal_bone_structure | 0.82068452 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.81966942 |
| 112 | MP0008874_decreased_physiological_sensi | 0.81703897 |
| 113 | MP0003448_altered_tumor_morphology | 0.80110561 |
| 114 | MP0005501_abnormal_skin_physiology | 0.80050520 |
| 115 | MP0000747_muscle_weakness | 0.79845895 |
| 116 | MP0005451_abnormal_body_composition | 0.79596122 |
| 117 | MP0004272_abnormal_basement_membrane | 0.76692038 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.75103392 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.74382442 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.74279487 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.74206288 |
| 122 | MP0003091_abnormal_cell_migration | 0.74007069 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.73228916 |
| 124 | MP0001853_heart_inflammation | 0.72910214 |
| 125 | MP0001881_abnormal_mammary_gland | 0.72902243 |
| 126 | MP0003941_abnormal_skin_development | 0.72701032 |
| 127 | MP0001243_abnormal_dermal_layer | 0.72267681 |
| 128 | MP0000371_diluted_coat_color | 0.71861152 |
| 129 | MP0002928_abnormal_bile_duct | 0.70304597 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.69967057 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.68796421 |
| 132 | MP0003633_abnormal_nervous_system | 0.68512746 |
| 133 | * MP0009642_abnormal_blood_homeostasis | 0.68479609 |
| 134 | MP0005334_abnormal_fat_pad | 0.67401913 |
| 135 | MP0002971_abnormal_brown_adipose | 0.67113151 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.66663983 |
| 137 | MP0001849_ear_inflammation | 0.64473861 |
| 138 | MP0000343_altered_response_to | 0.63208842 |
| 139 | MP0005448_abnormal_energy_balance | 0.63176581 |
| 140 | MP0005023_abnormal_wound_healing | 0.62710421 |
| 141 | MP0003868_abnormal_feces_composition | 0.61618017 |
| 142 | MP0005666_abnormal_adipose_tissue | 0.61576830 |
| 143 | MP0010307_abnormal_tumor_latency | 0.61340511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.94396497 |
| 2 | Xanthomatosis (HP:0000991) | 4.50387046 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.17408209 |
| 4 | Complement deficiency (HP:0004431) | 4.07156644 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.01285605 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.99355170 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.87625195 |
| 8 | Myocardial infarction (HP:0001658) | 3.84930813 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.76015324 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.64252841 |
| 11 | Joint hemorrhage (HP:0005261) | 3.54179840 |
| 12 | Eczematoid dermatitis (HP:0000976) | 3.51945051 |
| 13 | Abnormality of complement system (HP:0005339) | 3.44678451 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.42105536 |
| 15 | Axonal loss (HP:0003447) | 3.39691396 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.27368623 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.20814553 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20385580 |
| 19 | Nuclear cataract (HP:0100018) | 3.18296589 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.04244426 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84551676 |
| 22 | Epidermoid cyst (HP:0200040) | 2.82106838 |
| 23 | Hypercholesterolemia (HP:0003124) | 2.82060704 |
| 24 | Mutism (HP:0002300) | 2.79460663 |
| 25 | Premature rupture of membranes (HP:0001788) | 2.73910261 |
| 26 | Glomerulonephritis (HP:0000099) | 2.72775619 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.70691028 |
| 28 | Amyloidosis (HP:0011034) | 2.66785407 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 2.64385138 |
| 30 | Neuronal loss in central nervous system (HP:0002529) | 2.63104398 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.63104088 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.62358519 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55240018 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55240018 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55240018 |
| 36 | Thin bony cortex (HP:0002753) | 2.55235712 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.53428419 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.52961799 |
| 39 | Protrusio acetabuli (HP:0003179) | 2.51501915 |
| 40 | Diminished motivation (HP:0000745) | 2.50393355 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.48748356 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48748356 |
| 43 | Global brain atrophy (HP:0002283) | 2.44958350 |
| 44 | Skin nodule (HP:0200036) | 2.43191142 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.36343521 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.34134049 |
| 47 | Tetraparesis (HP:0002273) | 2.33937380 |
| 48 | Gingival bleeding (HP:0000225) | 2.33553730 |
| 49 | Sensorimotor neuropathy (HP:0007141) | 2.32927102 |
| 50 | Esophageal varix (HP:0002040) | 2.31431854 |
| 51 | Hydroxyprolinuria (HP:0003080) | 2.31058289 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.31058289 |
| 53 | Cervical subluxation (HP:0003308) | 2.31011047 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29478047 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29478047 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29478047 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28926616 |
| 58 | Nephritis (HP:0000123) | 2.27804896 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.26356129 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.26356129 |
| 61 | Achilles tendon contracture (HP:0001771) | 2.25993968 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.25680286 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.23515462 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22009861 |
| 65 | Menorrhagia (HP:0000132) | 2.21364967 |
| 66 | Hyperammonemia (HP:0001987) | 2.21197872 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.19837165 |
| 68 | Mitral stenosis (HP:0001718) | 2.19404225 |
| 69 | Thick nail (HP:0001805) | 2.18656145 |
| 70 | Bone pain (HP:0002653) | 2.18549930 |
| 71 | Hyperacusis (HP:0010780) | 2.18489093 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.17696668 |
| 73 | Loss of speech (HP:0002371) | 2.14247032 |
| 74 | Spondylolisthesis (HP:0003302) | 2.13521411 |
| 75 | Increased CSF protein (HP:0002922) | 2.13465141 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.13435992 |
| 77 | Disinhibition (HP:0000734) | 2.12929471 |
| 78 | Status epilepticus (HP:0002133) | 2.12604325 |
| 79 | Ketosis (HP:0001946) | 2.12544910 |
| 80 | Atrophic scars (HP:0001075) | 2.11314664 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.11177967 |
| 82 | Hyperglycinemia (HP:0002154) | 2.09537507 |
| 83 | Turricephaly (HP:0000262) | 2.09487549 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.05912830 |
| 85 | Neonatal onset (HP:0003623) | 2.04837301 |
| 86 | Increased serum ferritin (HP:0003281) | 2.04422578 |
| 87 | Upper motor neuron abnormality (HP:0002127) | 2.04117338 |
| 88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02655251 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.00810408 |
| 90 | Fat malabsorption (HP:0002630) | 1.98220954 |
| 91 | Natal tooth (HP:0000695) | 1.98020017 |
| 92 | Hyperglycinuria (HP:0003108) | 1.97580335 |
| 93 | Dementia (HP:0000726) | 1.95994546 |
| 94 | Spontaneous abortion (HP:0005268) | 1.95829879 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95209667 |
| 96 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92133227 |
| 97 | Peritonitis (HP:0002586) | 1.91580399 |
| 98 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90786352 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 1.90728727 |
| 100 | Neurofibrillary tangles (HP:0002185) | 1.90580772 |
| 101 | Thoracic kyphosis (HP:0002942) | 1.90534408 |
| 102 | Distal lower limb amyotrophy (HP:0008944) | 1.90286913 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 1.90112915 |
| 104 | Insomnia (HP:0100785) | 1.90009481 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.89902961 |
| 106 | Purpura (HP:0000979) | 1.89710364 |
| 107 | Joint stiffness (HP:0001387) | 1.89541501 |
| 108 | Metaphyseal irregularity (HP:0003025) | 1.89240213 |
| 109 | Peripheral demyelination (HP:0011096) | 1.89161408 |
| 110 | Stroke (HP:0001297) | 1.88786576 |
| 111 | Personality changes (HP:0000751) | 1.87854979 |
| 112 | Gingivitis (HP:0000230) | 1.87831200 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 1.87622195 |
| 114 | Abnormality of nail color (HP:0100643) | 1.86277041 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.86180235 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 1.86180235 |
| 117 | Cholelithiasis (HP:0001081) | 1.84655389 |
| 118 | Apathy (HP:0000741) | 1.84326449 |
| 119 | Cardiomegaly (HP:0001640) | 1.84035694 |
| 120 | Pathologic fracture (HP:0002756) | 1.83350722 |
| 121 | Ankle contracture (HP:0006466) | 1.82976490 |
| 122 | Spastic diplegia (HP:0001264) | 1.81638410 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.80873233 |
| 124 | Abnormality of glycine metabolism (HP:0010895) | 1.80579183 |
| 125 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80579183 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79882660 |
| 127 | Gout (HP:0001997) | 1.79344822 |
| 128 | Hyperparathyroidism (HP:0000843) | 1.78931565 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.78874647 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.76256769 |
| 131 | Protuberant abdomen (HP:0001538) | 1.75717000 |
| 132 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75458090 |
| 133 | Back pain (HP:0003418) | 1.75063492 |
| 134 | Reticulocytosis (HP:0001923) | 1.75035018 |
| 135 | Abnormal gallbladder morphology (HP:0012437) | 1.74993607 |
| 136 | Cerebral hemorrhage (HP:0001342) | 1.74738537 |
| 137 | Malnutrition (HP:0004395) | 1.71574276 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70210146 |
| 139 | Prolonged neonatal jaundice (HP:0006579) | 1.69772732 |
| 140 | Abnormality of the thoracic spine (HP:0100711) | 1.69674502 |
| 141 | Increased connective tissue (HP:0009025) | 1.68303102 |
| 142 | Short nail (HP:0001799) | 1.67503587 |
| 143 | Agnosia (HP:0010524) | 1.64131530 |
| 144 | Ulnar bowing (HP:0003031) | 1.63710765 |
| 145 | Fragile skin (HP:0001030) | 1.63515124 |
| 146 | Multiple lipomas (HP:0001012) | 1.63064631 |
| 147 | Genu recurvatum (HP:0002816) | 1.62355814 |
| 148 | Ovoid vertebral bodies (HP:0003300) | 1.60047462 |
| 149 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.55913317 |
| 150 | Vascular tortuosity (HP:0004948) | 1.51694098 |
| 151 | Hematochezia (HP:0002573) | 1.50454970 |
| 152 | Polycythemia (HP:0001901) | 1.49523740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.31194210 |
| 2 | NME2 | 3.26414962 |
| 3 | ERN1 | 3.21743552 |
| 4 | TRIB3 | 3.19738668 |
| 5 | FGFR4 | 2.53501936 |
| 6 | TAOK2 | 2.42754257 |
| 7 | RIPK4 | 2.35041335 |
| 8 | MAP3K9 | 2.24606356 |
| 9 | DDR2 | 2.21759659 |
| 10 | TBK1 | 2.21135941 |
| 11 | KSR2 | 2.19645450 |
| 12 | TYK2 | 2.15488349 |
| 13 | BMX | 2.06572904 |
| 14 | TGFBR2 | 2.03863744 |
| 15 | PKN2 | 2.02617072 |
| 16 | MAP3K14 | 1.96350376 |
| 17 | ICK | 1.95218710 |
| 18 | RIPK1 | 1.90319233 |
| 19 | MAP2K3 | 1.87500334 |
| 20 | IRAK3 | 1.81315002 |
| 21 | JAK1 | 1.80850737 |
| 22 | MAP3K2 | 1.74429830 |
| 23 | CDC42BPA | 1.69422151 |
| 24 | TAOK3 | 1.67247808 |
| 25 | DAPK2 | 1.63074997 |
| 26 | PTK6 | 1.58584530 |
| 27 | PAK4 | 1.54172736 |
| 28 | EPHB1 | 1.52315200 |
| 29 | NTRK1 | 1.50662519 |
| 30 | RET | 1.46818320 |
| 31 | JAK2 | 1.43580231 |
| 32 | SMG1 | 1.41497805 |
| 33 | PRKD3 | 1.38724391 |
| 34 | MAP2K4 | 1.38650475 |
| 35 | CAMKK1 | 1.36942980 |
| 36 | FGFR3 | 1.35812923 |
| 37 | GRK7 | 1.35312722 |
| 38 | LIMK1 | 1.26478731 |
| 39 | MAP3K1 | 1.26455966 |
| 40 | MST1R | 1.24983082 |
| 41 | TESK1 | 1.24549450 |
| 42 | TESK2 | 1.21408102 |
| 43 | ABL2 | 1.21351900 |
| 44 | ARAF | 1.20986144 |
| 45 | SIK1 | 1.18719657 |
| 46 | SCYL2 | 1.16229706 |
| 47 | PTK2 | 1.10828423 |
| 48 | MAP3K10 | 1.09978210 |
| 49 | TAOK1 | 1.09379103 |
| 50 | ALK | 1.04386558 |
| 51 | STK38 | 1.01831186 |
| 52 | MINK1 | 0.99582665 |
| 53 | FES | 0.99163308 |
| 54 | MAP3K11 | 0.98090044 |
| 55 | MAP3K13 | 0.96646839 |
| 56 | JAK3 | 0.96156449 |
| 57 | CAMK1D | 0.94557154 |
| 58 | PRKCH | 0.94303048 |
| 59 | EEF2K | 0.93713921 |
| 60 | HCK | 0.93584493 |
| 61 | EPHA3 | 0.90972398 |
| 62 | EPHB2 | 0.90144664 |
| 63 | IRAK2 | 0.89380778 |
| 64 | PDK2 | 0.89090307 |
| 65 | MAP4K1 | 0.88042182 |
| 66 | PRKD2 | 0.87870108 |
| 67 | LATS2 | 0.87859287 |
| 68 | CLK1 | 0.87544725 |
| 69 | EPHA2 | 0.85213137 |
| 70 | IKBKE | 0.85040052 |
| 71 | CSK | 0.84738368 |
| 72 | BLK | 0.84011169 |
| 73 | PAK6 | 0.83165737 |
| 74 | FER | 0.82984479 |
| 75 | SGK3 | 0.82827164 |
| 76 | PDPK1 | 0.82201234 |
| 77 | SIK2 | 0.80594654 |
| 78 | CAMK1G | 0.79961375 |
| 79 | PDGFRA | 0.79812568 |
| 80 | RPS6KC1 | 0.78000115 |
| 81 | RPS6KL1 | 0.78000115 |
| 82 | TYRO3 | 0.77863151 |
| 83 | MAPKAPK3 | 0.75510132 |
| 84 | LRRK2 | 0.74961320 |
| 85 | NEK9 | 0.73546825 |
| 86 | PDK1 | 0.72155599 |
| 87 | ERBB4 | 0.71098502 |
| 88 | MAP3K8 | 0.70975521 |
| 89 | CAMKK2 | 0.69716001 |
| 90 | IKBKB | 0.69309111 |
| 91 | PAK2 | 0.68778273 |
| 92 | MTOR | 0.67955673 |
| 93 | PBK | 0.66889916 |
| 94 | CDK6 | 0.66010841 |
| 95 | ZAP70 | 0.65532285 |
| 96 | RPS6KA2 | 0.65076995 |
| 97 | PIM2 | 0.62257978 |
| 98 | MAP2K1 | 0.61418792 |
| 99 | EGFR | 0.60966546 |
| 100 | MARK3 | 0.60882407 |
| 101 | NTRK3 | 0.60853114 |
| 102 | BRAF | 0.60421379 |
| 103 | KIT | 0.60174505 |
| 104 | MAP3K5 | 0.58892528 |
| 105 | MARK2 | 0.57799283 |
| 106 | SYK | 0.57187461 |
| 107 | DMPK | 0.55250917 |
| 108 | RPS6KA6 | 0.53832266 |
| 109 | KSR1 | 0.53772152 |
| 110 | PRKCZ | 0.53611078 |
| 111 | GRK5 | 0.52167126 |
| 112 | DAPK3 | 0.51906016 |
| 113 | CDK12 | 0.51815455 |
| 114 | BCKDK | 0.51716223 |
| 115 | CHUK | 0.51482457 |
| 116 | MAP3K6 | 0.50595772 |
| 117 | PTK2B | 0.50398142 |
| 118 | MAP3K3 | 0.49940301 |
| 119 | MATK | 0.48912474 |
| 120 | FGR | 0.47366833 |
| 121 | MAPK12 | 0.47129040 |
| 122 | MELK | 0.46791146 |
| 123 | IRAK4 | 0.46556148 |
| 124 | PDGFRB | 0.46252685 |
| 125 | SIK3 | 0.46012531 |
| 126 | TTN | 0.45930222 |
| 127 | CSF1R | 0.45862000 |
| 128 | ABL1 | 0.45587548 |
| 129 | MAPK7 | 0.44806863 |
| 130 | STK11 | 0.43657793 |
| 131 | MOS | 0.43323686 |
| 132 | PRKG2 | 0.41937871 |
| 133 | EPHA4 | 0.41561343 |
| 134 | MAP3K4 | 0.40662361 |
| 135 | MAP3K7 | 0.40542828 |
| 136 | STK10 | 0.39851392 |
| 137 | GSK3A | 0.39197653 |
| 138 | CDK15 | 0.34641813 |
| 139 | MAPKAPK2 | 0.33088303 |
| 140 | CDK11A | 0.32289000 |
| 141 | PAK1 | 0.32281138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.15914851 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.15666741 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.75789520 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33304855 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15532056 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55845111 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38919716 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.25972109 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.21567263 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.70543037 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59931848 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49579854 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.48275500 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44087679 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43438812 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40588868 |
| 17 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39045749 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38118228 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35963022 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.30743606 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30541301 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26663074 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24265023 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19606451 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17789252 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.16897783 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.12704808 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12388665 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12308747 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11017581 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10904405 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10267504 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06866805 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06251832 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05003971 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03991849 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 0.99726250 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99550173 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99501088 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 0.98255687 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96625917 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94780936 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94705041 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.94435547 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93567691 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92595663 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92511106 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91912292 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.91579633 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88865627 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.88029644 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85245918 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85083519 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83323002 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79808621 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78645662 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.78539782 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77871257 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.77584699 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77526906 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77126782 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76196742 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75569575 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75478489 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74957830 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74859885 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.73864557 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.71961590 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71756051 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71366172 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71042768 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69848026 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69137566 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69061737 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68977039 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68118499 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67221277 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.66609441 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66355606 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64453786 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64215009 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64042832 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63622377 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62598588 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62481176 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.61768743 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61701041 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60592159 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60437469 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60059500 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59962894 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59469883 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59190211 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59059535 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58733605 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.58420778 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58122827 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57933159 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57495652 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.57424672 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56625887 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.56595032 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56089498 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56083682 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55983827 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55700299 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53834166 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52816056 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52769402 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52289828 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52137032 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51487675 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.51245266 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50908346 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.50631732 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50563370 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50050040 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49537807 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49008067 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.48600946 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48019270 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47590525 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47344638 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46462371 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46384868 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46282479 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45853257 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45714768 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45531099 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.45277971 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43320401 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42034848 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41663579 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39856495 |
| 135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38857835 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.38609844 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38414969 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38132500 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37911155 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36419489 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35735670 |
| 142 | Apoptosis_Homo sapiens_hsa04210 | 0.33529404 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33260493 |
| 144 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33039343 |
| 145 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32422749 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.32278937 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32053094 |
| 148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31946118 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.31520732 |

